Environment Topics

The On-Topic Netowork

Environment > In Vivo


In Vivo
In Vivo
In Vivo
In Vivo
In Vivo

The following information is about In Vivo.

In Vivo Defined

Testing or action inside an organism.

This definition is in context to Environment. See more contextual defintions for In Vivo.


Navigation: [ 1 2 3 Next ]

Taconic Europe A/S Receives AAALAC Accreditation

Published August 21, 2008, 2:34 pm, Business Wire via Yahoo! Finance

HUDSON, N.Y.----Taconic announced that its Taconic Europe A/S operation in Denmark has received full accreditation from AAALAC International, making it the first and only European Union commercial rat and mouse breeder to receive AAALAC accreditation.

Full Story


JCI table of contents: Aug. 21, 2008

Published August 21, 2008, 2:27 pm, EurekAlert!

( Journal of Clinical Investigation ) This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published Aug. 21, 2008, in the JCI: "Antitumor effects are enhanced by inhibiting 2 pathways rather than 1"; "Molecular insight into one form of the bleeding disorder von Willebrand disease"; and "Insight into the physiologic role of the blood ...

Full Story


Anti-tumor effects are enhanced by inhibiting 2 pathways rather than 1

Published August 21, 2008, 2:26 pm, EurekAlert!

( Journal of Clinical Investigation ) Two independent research groups have found that simultaneous inhibition of two signaling pathways -- mTOR and MAPK signaling pathways -- results in substantially enhanced antitumor effects when compared with inhibition of either pathway alone in mouse models of prostate and breast cancer.

Full Story


PolyMedix Initiates Dosing in Phase I Clinical Study of Novel Systemic Antibiotic Compound

Published August 21, 2008, 5:31 am, Business Wire via Yahoo! Finance

RADNOR, Pa.----PolyMedix, Inc. , an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has initiated dosing and commenced a Phase I clinical study in Canada for its defensin mimetic antibiotic compound, PMX-30063.

Full Story


News From The Journal Of Neuroscience

Published August 21, 2008, 3:16 am, Medical News Today

1. Wnt Effects on Growth Cone Microtubules Silvia A. Purro, Lorenza Ciani, Monica Hoyos-Flight, Eleanna Stamatakou, Eliza Siomou, and Patricia C. Salinas Wnt family proteins are secreted from target tissues and regulate axonal terminal arborization during development.

Full Story


Arpida's iclaprim MAA Accepted for Review by EMEA

Published August 21, 2008, 2:14 am, PR Newswire via Yahoo! Finance

Arpida Ltd. today announced that the European Medicines Agency has accepted for review its Marketing Authorisation Application for intravenous iclaprim. Arpida is seeking approval of intravenous iclaprim in the European Union for the treatment of complicated Skin and Soft Tissue Infections .

Full Story


Carnegie Mellon MRI technology that non-invasively locates, quantifies specific cells in the body

Published August 20, 2008, 10:38 pm, EurekAlert!

( Carnegie Mellon University ) MRI isn't just for capturing detailed images of the body's anatomy. Thanks to imaging reagents and technology developed by Carnegie Mellon, MRI can be used to visualize -- with "exquisite" specificity -- cell populations in the living body. The ability to non-invasively locate and track cells, will greatly aid the study and treatment of cancer, inflammation, and ...

Full Story


Brain Cells Called Astrocytes Undergo Reorganization And May Engulf Attacking T Cells

Published August 20, 2008, 7:14 am, Medical News Today

When virally infected cells in the brain called astrocytes come in contact with anti-viral T cells of the immune system, they undergo a unique series of changes that dramatically reorganize their shape and function, according to researchers at the Board of Governors Gene Therapeutics Research Institute at Cedars-Sinai Medical Center.

Full Story


RegeneRx Completes Patient Enrollment of First Phase II Clinical Trial

Published August 20, 2008, 5:48 am, Centre Daily Times

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it completed enrollment of its first of four ongoing Phase II clinical trials. The trial is a double-blind, placebo-controlled, dose-escalating clinical trial evaluating the safety and efficacy of the Company's topical drug candidate, RGN-137, in seventy-two patients with pressure ulcers who are being treated ...

Full Story


RegeneRx Completes Patient Enrollment of First Phase II Clinical Trial

Published August 20, 2008, 5:30 am, Business Wire via Yahoo! Finance

BETHESDA, Md.----REGENERX BIOPHARMACEUTICALS, INC. announced today that it completed enrollment of its first of four ongoing Phase II clinical trials. The trial is a double-blind, placebo-controlled, dose-escalating clinical trial evaluating the safety and efficacy of the Company's topical drug candidate, RGN-137, in seventy-two patients with pressure ulcers who are being treated for up to 84 ...

Full Story


Navigation: [ 1 2 3 Next ]

Are you looking for additional Environment > In Vivo news? Try our new "In Vivo News Focus" area.

Off-site In Vivo Links, User Submitted

The following links have been collected through user bookmark submission in the In Vivo category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Thu Aug 7

Wed Jul 30

Wed Apr 16

Thu Sep 20

Tue Aug 21

Wed Jun 20

Mon Jun 11

Mon Apr 16

Sat Feb 3

Tue Jan 23

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > In Vivo. If you would like to find related tags we recommend Tag Patterns > In Vivo

Off-site In Vivo Research Links

If you still need additional information on In Vivo then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Environment

If you know the Environment Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Environment.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a